Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 23391965)

1.

Social network support for individuals receiving opiate substitution treatment and its association with treatment progress.

Day E, Copello A, Karia M, Roche J, Grewal P, George S, Haque S, Chohan G.

Eur Addict Res. 2013;19(4):211-21. doi: 10.1159/000343827. Epub 2013 Feb 7.

PMID:
23391965
2.

Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial.

Day E, Copello A, Seddon JL, Christie M, Bamber D, Powell C, George S, Ball A, Frew E, Freemantle N.

Trials. 2013 Aug 19;14:264. doi: 10.1186/1745-6215-14-264.

3.

Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals.

Fatseas M, Denis C, Massida Z, Verger M, Franques-Rénéric P, Auriacombe M.

Biol Psychiatry. 2011 Oct 15;70(8):720-7. doi: 10.1016/j.biopsych.2011.05.015. Epub 2011 Jul 8.

PMID:
21741031
4.

Concurrent heroin use among methadone maintenance clients in China.

Li L, Lin C, Wan D, Zhang L, Lai W.

Addict Behav. 2012 Mar;37(3):264-8. doi: 10.1016/j.addbeh.2011.11.004. Epub 2011 Nov 7.

5.

Predicting biopsychosocial outcomes for heroin users in primary care treatment: a prospective longitudinal cohort study.

Parmenter J, Mitchell C, Keen J, Oliver P, Rowse G, Neligan I, Keil C, Mathers N.

Br J Gen Pract. 2013 Jul;63(612):e499-505. doi: 10.3399/bjgp13X669220.

6.

Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.

Maas J, Barton G, Maskrey V, Pinto H, Holland R.

Drug Alcohol Depend. 2013 Dec 1;133(2):494-501. doi: 10.1016/j.drugalcdep.2013.07.018. Epub 2013 Aug 17.

PMID:
23962419
7.

Engagement, retention, and abstinence for three types of opioid users in Florida.

McCabe BE, Santisteban DA, Mena MP, Duchene DM, McLean C, Monroe M.

Subst Use Misuse. 2013 Jun;48(8):623-34. doi: 10.3109/10826084.2013.800112. Epub 2013 Jun 10.

8.

Craving and illicit heroin use among patients in heroin-assisted treatment.

Blanken P, Hendriks VM, Koeter MW, van Ree JM, van den Brink W.

Drug Alcohol Depend. 2012 Jan 1;120(1-3):74-80. doi: 10.1016/j.drugalcdep.2011.06.025. Epub 2011 Jul 22.

PMID:
21782351
9.

Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.

Vigezzi P, Guglielmino L, Marzorati P, Silenzio R, De Chiara M, Corrado F, Cocchi L, Cozzolino E.

J Subst Abuse Treat. 2006 Jul;31(1):3-7. Review.

PMID:
16814005
10.

Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.

McKeganey N, Russell C, Cockayne L.

J Subst Abuse Treat. 2013 Jan;44(1):97-102. doi: 10.1016/j.jsat.2012.04.003. Epub 2012 Jun 15.

PMID:
22703715
11.

Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France.

Guichard A, Lert F, Calderon C, Gaigi H, Maguet O, Soletti J, Brodeur JM, Richard L, Benigeri M, Zunzunegui MV.

Addiction. 2003 Nov;98(11):1585-97.

PMID:
14616185
12.

Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.

Wang PW, Wu HC, Yen CN, Yeh YC, Chung KS, Chang HC, Yen CF.

Am J Drug Alcohol Abuse. 2012 May;38(3):213-9. doi: 10.3109/00952990.2011.649222. Epub 2012 Feb 22.

PMID:
22352836
13.

Heroin anticraving medications: a systematic review.

Fareed A, Vayalapalli S, Casarella J, Amar R, Drexler K.

Am J Drug Alcohol Abuse. 2010 Nov;36(6):332-41. doi: 10.3109/00952990.2010.505991. Epub 2010 Oct 19. Review.

PMID:
20955107
14.

Stigma and its determinants among male drug dependents receiving methadone maintenance treatment.

Etesam F, Assarian F, Hosseini H, Ghoreishi FS.

Arch Iran Med. 2014 Feb;17(2):108-14. doi: 014172/AIM.005.

15.

Can heroin-dependent individuals benefit from a methadone maintenance treatment program before they drop out against medical advice? A 12-month follow-up study.

Wang PW, Wu HC, Lin HC, Yen CN, Yeh YC, Chung KS, Chang HC, Yen CF.

Eur Addict Res. 2013;19(3):155-64. doi: 10.1159/000342309. Epub 2012 Nov 23.

PMID:
23182770
16.

Cingulate biochemistry in heroin users on substitution pharmacotherapy.

Verdejo-García A, Lubman DI, Roffel K, Vilar-López R, Bora E, MacKenzie T, Yücel M.

Aust N Z J Psychiatry. 2013 Mar;47(3):244-9. doi: 10.1177/0004867412463088. Epub 2012 Oct 11.

PMID:
23060530
17.

Predictors for dropping-out from methadone maintenance therapy programs among heroin users in southern Taiwan.

Lin HC, Chen KY, Wang PW, Yen CF, Wu HC, Yen CN, Yeh YC, Chung KS, Chang HC.

Subst Use Misuse. 2013 Jan;48(1-2):181-91. doi: 10.3109/10826084.2012.749411.

PMID:
23368704
18.

Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy.

Pajusco B, Chiamulera C, Quaglio G, Moro L, Casari R, Amen G, Faccini M, Lugoboni F.

Int J Environ Res Public Health. 2012 Mar;9(3):932-42. doi: 10.3390/ijerph9030932. Epub 2012 Mar 16.

19.

Persistence of heroin use despite methadone treatment: poor coping self-efficacy predicts continued heroin use.

Senbanjo R, Wolff K, Marshall EJ, Strang J.

Drug Alcohol Rev. 2009 Nov;28(6):608-15. doi: 10.1111/j.1465-3362.2009.00064.x.

PMID:
19930013
20.

Explicit and implicit heroin-related cognitions and heroin use among patients receiving methadone maintenance treatment.

Wang PW, Lin HC, Wu HC, Hsu CY, Chung KS, Ko CH, Yen CF.

Compr Psychiatry. 2015 Jan;56:155-60. doi: 10.1016/j.comppsych.2014.08.047. Epub 2014 Aug 19.

PMID:
25263518
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk